Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions
作者： M. D. Lee , E. Ayanoglu , L. Gong
DOI: 10.1080/00498250600861785
关键词: Drug metabolism 、 Drug 、 Gene 、 Biology 、 Reductase 、 Enzyme 、 Pharmacology 、 Agonist 、 Regulation of gene expression 、 Cytochrome P450
摘要: … been updated and reorganized into drug–cytochrome P450 matrices in order to facilitate … drugs from 265 examined were found to be cytochrome P450 inducers, and 83 were found to …
informahealthcare.com参考文章(499)
C R Wolf, G Smith, Cytochrome P450 CYP2D6. IARC scientific publications. pp. 209- ,(1999)
Susumu Imaoka, Takao Yamada, Toyoko Hiroi, Koji Hayashi, Toshiyuki Sakaki, Yoshiyasu Yabusaki, Yoshihiko Funae, Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochemical Pharmacology. ,vol. 51, pp. 1041- 1050 ,(1996) , 10.1016/0006-2952(96)00052-4
Andr?? J Scheen, Drug interactions of clinical importance with antihyperglycaemic agents: an update. Drug Safety. ,vol. 28, pp. 601- 631 ,(2005) , 10.2165/00002018-200528070-00004
Monika Szewczuk-Bogusławska, Andrzej Kiejna, Jan A Beszłej, Krystyna Orzechowska-Juzwenko, Piotr Milejski, Doxepin inhibits CYP2D6 activity in vivo. Polish Journal of Pharmacology. ,vol. 56, pp. 491- 494 ,(2004)
Jørgen G Bramness, Jørg Mørland, Anders Molven, Vidar M Steen, Svetlana Skurtveit, Lars Fauske, Merete Grung, Association between blood carisoprodol:meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects? Pharmacogenetics. ,vol. 13, pp. 383- 388 ,(2003) , 10.1097/01.FPC.0000054098.48725.88
Koichi Otani, Cytochrome P450 3A4 and Benzodiazepines Psychiatria et neurologia Japonica. ,vol. 105, pp. 631- 642 ,(2003)
Frenia K, Beers Mh, Baran Rw, Drugs and the elderly, Part 1: The problems facing managed care. The American Journal of Managed Care. ,vol. 6, pp. 1313- ,(2000)
Andras Vermes, Istvan Vermes, Genetic polymorphisms in cytochrome P450 enzymes: effect on efficacy and tolerability of HMG-CoA reductase inhibitors. American Journal of Cardiovascular Drugs. ,vol. 4, pp. 247- 255 ,(2004) , 10.2165/00129784-200404040-00005
Steven A. Wrighton, Barbara J. Ring, Inhibition of human CYP3A catalyzed 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine. Pharmaceutical Research. ,vol. 11, pp. 921- 924 ,(1994) , 10.1023/A:1018906614320
Hiral D. Desai, Julia Seabolt, Michael W. Jann, Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. ,vol. 15, pp. 469- 494 ,(2001) , 10.2165/00023210-200115060-00005